SpyGlass Pharma, Inc.

Healthcare · Biotechnology · United States

Last price 32.51 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.09B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was...